Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.

Ulz P, Perakis S, Zhou Q, Moser T, Belic J, Lazzeri I, W├Âlfler A, Zebisch A, Gerger A, Pristauz G, Petru E, White B, Roberts CES, John JS, Schimek MG, Geigl JB, Bauernhofer T, Sill H, Bock C, Heitzer E, Speicher MR.

Nat Commun. 2019 Oct 11;10(1):4666. doi: 10.1038/s41467-019-12714-4.

2.

The potential of liquid biopsies for the early detection of cancer.

Heitzer E, Perakis S, Geigl JB, Speicher MR.

NPJ Precis Oncol. 2017 Oct 17;1(1):36. doi: 10.1038/s41698-017-0039-5. eCollection 2017. Review.

3.

Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide.

Belic J, Graf R, Bauernhofer T, Cherkas Y, Ulz P, Waldispuehl-Geigl J, Perakis S, Gormley M, Patel J, Li W, Geigl JB, Smirnov D, Heitzer E, Gross M, Speicher MR.

Int J Cancer. 2018 Sep 1;143(5):1236-1248. doi: 10.1002/ijc.31397. Epub 2018 Apr 10.

4.

Single-Stranded DNA Library Preparation Does Not Preferentially Enrich Circulating Tumor DNA.

Moser T, Ulz P, Zhou Q, Perakis S, Geigl JB, Speicher MR, Heitzer E.

Clin Chem. 2017 Oct;63(10):1656-1659. doi: 10.1373/clinchem.2017.277988. Epub 2017 Aug 14. No abstract available.

5.

Advances in Circulating Tumor DNA Analysis.

Perakis S, Auer M, Belic J, Heitzer E.

Adv Clin Chem. 2017;80:73-153. doi: 10.1016/bs.acc.2016.11.005. Epub 2017 Jan 3.

PMID:
28431643
6.

Emerging concepts in liquid biopsies.

Perakis S, Speicher MR.

BMC Med. 2017 Apr 6;15(1):75. doi: 10.1186/s12916-017-0840-6. Review.

7.

Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.

Perakis SO, Thomas JE, Pichler M.

Adv Exp Med Biol. 2016;937:183-204. doi: 10.1007/978-3-319-42059-2_10. Review.

PMID:
27573901
8.

Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.

Seles M, Hutterer GC, Kiesslich T, Pummer K, Berindan-Neagoe I, Perakis S, Schwarzenbacher D, Stotz M, Gerger A, Pichler M.

Int J Mol Sci. 2016 Apr 15;17(4):573. doi: 10.3390/ijms17040573. Review.

9.

microRNAs and Colorectal Cancer.

Ress AL, Perakis S, Pichler M.

Adv Exp Med Biol. 2015;889:89-103. doi: 10.1007/978-3-319-23730-5_6.

PMID:
26658998
10.

Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.

Ress AL, Stiegelbauer V, Schwarzenbacher D, Deutsch A, Perakis S, Ling H, Ivan C, Calin GA, Rinner B, Gerger A, Pichler M.

Oncotarget. 2014 Sep 30;5(18):8492-502.

11.

MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.

Stiegelbauer V, Perakis S, Deutsch A, Ling H, Gerger A, Pichler M.

World J Gastroenterol. 2014 Sep 7;20(33):11727-35. doi: 10.3748/wjg.v20.i33.11727. Review.

12.

Tumor endothelial inflammation predicts clinical outcome in diverse human cancers.

Pitroda SP, Zhou T, Sweis RF, Filippo M, Labay E, Beckett MA, Mauceri HJ, Liang H, Darga TE, Perakis S, Khan SA, Sutton HG, Zhang W, Khodarev NN, Garcia JG, Weichselbaum RR.

PLoS One. 2012;7(10):e46104. doi: 10.1371/journal.pone.0046104. Epub 2012 Oct 4.

13.

MicroRNA expression characterizes oligometastasis(es).

Lussier YA, Xing HR, Salama JK, Khodarev NN, Huang Y, Zhang Q, Khan SA, Yang X, Hasselle MD, Darga TE, Malik R, Fan H, Perakis S, Filippo M, Corbin K, Lee Y, Posner MC, Chmura SJ, Hellman S, Weichselbaum RR.

PLoS One. 2011;6(12):e28650. doi: 10.1371/journal.pone.0028650. Epub 2011 Dec 13.

Supplemental Content

Loading ...
Support Center